Baverel Laurent, Boutsiadis Achilleas, Reynolds Ryan J, Saffarini Mo, Barthélémy Renaud, Barth Johannes
Department of Orthopaedic Surgery, Centre Osteoarticulaire des Cèdres, Grenoble, France.
ReSurg, Nyon, Switzerland.
JSES Open Access. 2017 Dec 19;2(1):54-59. doi: 10.1016/j.jses.2017.11.005. eCollection 2018 Mar.
Rotator cuff tears are associated with capsular contraction and stiffness that should be restored before surgical repair. Corticosteroid injections (CSIs) are frequently used as conservative treatments before surgical repair. This study aimed to determine the influence of preoperative and postoperative CSIs on clinical and anatomic outcomes after rotator cuff repair.
The authors analyzed the records of 257 patients who had arthroscopic rotator cuff repair, of whom 212 were evaluated at 3.1 ± 1.0 years (median, 2.9 years; range, 1.4-7.1 years) by clinical (Constant score) and ultrasound (Sugaya classification) examinations. Univariable and multivariable regressions were performed to determine associations between outcomes and administration of preoperative and postoperative CSIs, patient characteristics, and tendon characteristics.
The Constant scores improved from 56.4 ± 15.1 to 80.8 ± 12.5. Multivariable regression confirmed that postoperative scores were associated with postoperative CSIs ( < .001), preoperative scores ( < .001), gender ( < .001), and fatty infiltration ( < .005). Retears (Sugaya types IV-V) were observed in 27 shoulders (13%). Multivariable regression clarified that retear rates were associated only with postoperative CSIs ( = .007) and stage 3 fatty infiltration ( = .001). Adjusting for confounders, an additional postoperative CSI would decrease scores by 4.7 points and double retear risks.
Preoperative CSIs had no influence on clinical scores and retear rates, whereas postoperative CSIs were associated with lower scores and more retears. Although we can infer that preoperative CSIs do not affect outcomes, we cannot determine whether postoperative CSIs compromised outcomes or were administered in patients who had already poor outcomes. Our findings may resolve controversies about the administration of preoperative CSIs.
肩袖撕裂与关节囊挛缩和僵硬相关,在手术修复前应予以恢复。皮质类固醇注射(CSIs)常被用作手术修复前的保守治疗方法。本研究旨在确定术前和术后CSIs对肩袖修复术后临床和解剖学结果的影响。
作者分析了257例行关节镜下肩袖修复患者的记录,其中212例在3.1±1.0年(中位数2.9年;范围1.4 - 7.1年)时接受了临床(Constant评分)和超声(Sugaya分类)检查。进行单变量和多变量回归分析,以确定结果与术前和术后CSIs的使用、患者特征以及肌腱特征之间的关联。
Constant评分从56.4±15.1提高到80.8±12.5。多变量回归证实,术后评分与术后CSIs(<0.001)、术前评分(<0.001)、性别(<0.001)和脂肪浸润(<0.005)相关。在27个肩部(13%)观察到再撕裂(Sugaya IV - V型)。多变量回归表明,再撕裂率仅与术后CSIs(=0.007)和3期脂肪浸润(=0.001)相关。校正混杂因素后,额外的术后CSIs会使评分降低4.7分,并使再撕裂风险加倍。
术前CSIs对临床评分和再撕裂率没有影响,而术后CSIs与较低的评分和更多的再撕裂相关。虽然我们可以推断术前CSIs不影响结果,但我们无法确定术后CSIs是损害了结果还是用于已经预后不良的患者。我们的研究结果可能会解决关于术前CSIs使用的争议。